BVF INC/IL Diversified Active

CIK: 0001056807 · Show all filings

Period: Q3 2017 (← Previous) (Next →)

Filing Date: Nov 14, 2017

Total Value ($000): $786,726 (97.5% shares, 2.5% debt)

Holdings (37)

ARRAY BIOPHARMA INC 10.0%
Value ($000) $78,751 Shares 6,402,525 Est. Cost $6.82 Unrealized
BLUEPRINT MEDICINES CORP 8.9%
Value ($000) $70,182 Shares 1,007,354 Est. Cost $25.16 Unrealized
CHEMOCENTRYX INC 7.2%
Value ($000) $56,299 Shares 7,587,416 Est. Cost $8.94 Unrealized
ANAB ANAPTYSBIO INC 6.1%
Value ($000) $48,201 Shares 1,379,134 Est. Cost $23.32 Unrealized +15.7%
CONCERT PHARMACEUTICALS INC 5.9%
Value ($000) $46,246 Shares 3,135,289 Est. Cost $14.18 Unrealized
GLYCOMIMETICS INC 5.7%
Value ($000) $45,186 Shares 3,229,856 Est. Cost $7.84 Unrealized
IRWD IRONWOOD PHARMACEUTICALS INC 5.7%
Value ($000) $44,471 Shares 2,820,000 Est. Cost $13.76 Unrealized 0.0%
CTMX CYTOMX THERAPEUTICS INC 5.2%
Value ($000) $40,535 Shares 2,230,898 Est. Cost $14.24 Unrealized +9.6%
XOMA XOMA CORP DEL 3.8%
Value ($000) $29,530 Shares 1,502,800 Est. Cost $5.35 Unrealized +108.6%
BIOLINERX LTD 3.7%
Value ($000) $29,115 Shares 25,995,575 Est. Cost $1.01 Unrealized
CTI BIOPHARMA CORP 3.5%
Value ($000) $27,422 Shares 8,596,357 Est. Cost $3.77 Unrealized
LOXO ONCOLOGY INC 2.8%
Value ($000) $21,960 Shares 238,386 Est. Cost $53.87 Unrealized
KURA KURA ONCOLOGY INC 2.6%
Value ($000) $20,240 Shares 1,353,846 Est. Cost $9.39 Unrealized 0.0%
ONCOMED PHARMACEUTICALS INC 2.5%
Value ($000) $19,889 Shares 4,400,289 Est. Cost $8.77 Unrealized
ZEALAND PHARMA A S 2.4%
Value ($000) $19,200 Shares 1,000,000 Est. Cost $19.20 Unrealized
CYTK CYTOKINETICS INC 2.3%
Value ($000) $17,995 Shares 1,241,021 Est. Cost $7.03 Unrealized +94.3%
PIERIS PHARMACEUTICALS INC 2.2%
Value ($000) $17,203 Shares 2,986,562 Est. Cost $3.18 Unrealized
REGULUS THERAPEUTICS INC 2.1%
Value ($000) $16,187 Shares 12,949,229 Est. Cost $1.22 Unrealized
INTRA CELLULAR THERAPIES INC 1.9%
Value ($000) $14,991 Shares 950,000 Est. Cost $15.78 Unrealized
TOCAGEN INC 1.7%
Value ($000) $13,245 Shares 1,063,028 Est. Cost $12.03 Unrealized
CASCADIAN THERAPEUTICS INC 1.6%
Value ($000) $12,815 Shares 3,133,224 Est. Cost $4.31 Unrealized
SPRING BK PHARMACEUTICALS INC 1.4%
Value ($000) $10,991 Shares 652,676 Est. Cost $13.73 Unrealized
XENE XENON PHARMACEUTICALS INC 1.3%
Value ($000) $10,587 Shares 3,588,830 Est. Cost $8.35 Unrealized -62.9%
INFIQ INFINITY PHARMACEUTICALS INC 1.3%
Value ($000) $10,462 Shares 7,866,108 Est. Cost $3.51 Unrealized -64.7%
GTX INC DEL 1.2%
Value ($000) $9,111 Shares 1,108,433 Est. Cost $5.28 Unrealized
FORWARD PHARMA A/S 1.1%
Value ($000) $8,571 Shares 1,455,117 Est. Cost $20.16 Unrealized
ARQULE INC 1.0%
Value ($000) $8,214 Shares 7,400,128 Est. Cost $1.87 Unrealized
ALPINE IMMUNE SCIENCES INC 1.0%
Value ($000) $7,839 Shares 675,759 Est. Cost $11.60 Unrealized
CRVS CORVUS PHARMACEUTICALS INC 0.9%
Value ($000) $7,323 Shares 459,396 Est. Cost $11.95 Unrealized +15.8%
MOLECULAR TEMPLATES INC 0.6%
Value ($000) $5,047 Shares 724,132 Est. Cost $6.97 Unrealized
OREXIGEN THERAPEUTICS INC 0.6%
Value ($000) $4,769 Shares 10,000,000 Est. Cost $0.27 Unrealized
SUNESIS PHARMACEUTICALS INC 0.5%
Value ($000) $3,964 Shares 2,043,196 Est. Cost $3.60 Unrealized
CONTRAFECT CORP 0.5%
Value ($000) $3,885 Shares 3,500,000 Est. Cost $1.11 Unrealized
ADURO BIOTECH INC 0.3%
Value ($000) $1,968 Shares 184,764 Est. Cost $11.40 Unrealized
OREXIGEN THERAPEUTICS INC 0.2%
Value ($000) $1,558 Shares 734,976 Est. Cost $3.32 Unrealized
ANTH ANTHERA PHARMACEUTICALS INC 0.2%
Value ($000) $1,449 Shares 1,006,507 Est. Cost $2.24 Unrealized -36.6%
PAIN THERAPEUTICS INC 0.2%
Value ($000) $1,325 Shares 325,508 Est. Cost $4.12 Unrealized